Mortality News and Research

RSS

New tool uses artificial intelligence to calculate harmful effects of medicines

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more likely to experience adverse anticholinergic effects on the body and brain.

7 Sep 2022

Plant production of nanobodies that neutralize the interaction between ACE2 receptor and SARS-CoV-2 spike protein

Researchers demonstrated the production of nanobodies against SARS-CoV-2 spike protein.

7 Sep 2022

Is male hypogonadism a risk factor for hospitalization for COVID-19?

Researchers found an association between male hypogonadism and hospitalization risk for COVID-19.

7 Sep 2022

How have worldwide physical activity trends changed since the onset of the COVID-19 pandemic?

Researchers assessed the trends in physical activity worldwide since the onset of COVID-19.

7 Sep 2022

Noninvasive respiratory support may not benefit nano-preterm infants, study suggests

Extremely premature infants still face daunting risks of sickness or death, even though advances in neonatal-perinatal care have improved infant survival at progressively lower gestational ages. Bronchopulmonary dysplasia - a serious condition of undeveloped lungs - is a leading morbidity in these tiny infants.

6 Sep 2022

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

6 Sep 2022

Cedars-Sinai investigators identify 15 cancer disparities in L.A. County

People in Los Angeles County experience differences in cancer risk and survival depending on a variety of factors such as race/ethnicity, gender, sexual orientation, geographic location and socioeconomic status, according to a new study by investigators at Cedars-Sinai Cancer.

6 Sep 2022

The virology, epidemiology, transmission, clinical manifestations, diagnosis, management, and prevention strategies associated with monkeypox

Scientists have described the epidemiology, transmission, clinical features, diagnosis, treatment, and preventive strategies of monkeypox infection among humans.

6 Sep 2022

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Researchers discussed possible mechanisms and potential treatment methods for endotheliopathy observed in patients with post-acute sequelae of SARS-CoV-2 infection.

6 Sep 2022

Neurological manifestations associated with monkeypox infection

A new study presents current information regarding the neurological presentations and complications of monkeypox infection.

5 Sep 2022

Inequalities are the most significant threat to public health, top doctor warns

Inequalities are the most significant threat to public health in the UK, a top doctor has warned ahead of a major conference at the Royal Society of Medicine.

5 Sep 2022

Regular moderate-intensity exercise may reduce risk of COVID-19 infection and severity

Regular physical activity is linked to a lower risk of COVID-19 infection and severity, including hospital admission and death, finds a pooled data analysis of the available evidence, published online in the British Journal of Sports Medicine.

5 Sep 2022

Researchers compare the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy

Researchers compared the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy.

5 Sep 2022

Covid-19 study highlights a continued drop in U.S. life expectancy

An updated analysis of American COVID-19 deaths throughout 2021 highlights a continued drop in overall life expectancy as well as persistent disparities by race and ethnicity.

2 Sep 2022

Private equity ownership of physician practices may impose measures to squeeze out more profits, research says

New research reveals private equity firms that acquire physician-owned medical practices appear to be imposing measures to squeeze out more profits.

2 Sep 2022

Animal study brings hope for the use of more donor lungs in future

A large amount of lungs donated cannot be used for transplantation. Researchers at Lund University in Sweden and Skåne University Hospital have conducted an animal study bringing hope that more donor lungs could be used in the future.

2 Sep 2022

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Researchers summarized existing data on the immunogenicity of COVID-19 vaccines and the humoral and cellular immune responses against SARS-CoV-2.

2 Sep 2022

Study opens a window of opportunity to design RAF1 degraders against lung adenocarcinomas

One of the main challenges in oncology is the development of drugs against KRAS oncogenes. These oncogenes -genes that cause cancer when mutated - are responsible for a quarter of all human cancers, including the three tumor types with the highest mortality rates: lung adenocarcinoma, colorectal carcinoma and pancreatic ductal adenocarcinoma.

1 Sep 2022

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

In a new study, researchers illustrated that metformin was associated with decreased coronavirus disease 2019 (COVID-19) severity among prediabetic patients.

1 Sep 2022

How does origin impact antiviral immune response?

A new study observed differential antiviral responses in Indian and European individuals.

1 Sep 2022

Mortality News and Research

New tool uses artificial intelligence to calculate harmful effects of medicines

Plant production of nanobodies that neutralize the interaction between ACE2 receptor and SARS-CoV-2 spike protein

Is male hypogonadism a risk factor for hospitalization for COVID-19?

How have worldwide physical activity trends changed since the onset of the COVID-19 pandemic?

Noninvasive respiratory support may not benefit nano-preterm infants, study suggests

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Cedars-Sinai investigators identify 15 cancer disparities in L.A. County

The virology, epidemiology, transmission, clinical manifestations, diagnosis, management, and prevention strategies associated with monkeypox

Review explores the involvement of the endothelium as an important underpinning of long COVID’s pathophysiology

Neurological manifestations associated with monkeypox infection

Inequalities are the most significant threat to public health, top doctor warns

Regular moderate-intensity exercise may reduce risk of COVID-19 infection and severity

Researchers compare the percent excess mortalities due to the zero-COVID-19 policy or the living-with-COVID policy

Covid-19 study highlights a continued drop in U.S. life expectancy

Private equity ownership of physician practices may impose measures to squeeze out more profits, research says

Animal study brings hope for the use of more donor lungs in future

What is currently known about immune responses to COVID-19 vaccines and cellular immune responses against SARS-CoV-2?

Study opens a window of opportunity to design RAF1 degraders against lung adenocarcinomas

New study suggests metformin is associated with less severe COVID-19 across prediabetic individuals

How does origin impact antiviral immune response?

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News